(Q36814991)

16 August 2017

1 reference

title

Angiotensin-converting enzyme inhibitors and coronary heart disease prevention (English)

1 reference

16 August 2017

1 reference

coronary artery disease

1 reference

Richard Donnelly

1

1 reference

16 August 2017

Gillian Manning

series ordinal

2

1 reference

16 August 2017

publication date

1 March 2007

1 reference

Journal of the Renin-Angiotensin-Aldosterone System

16 August 2017

published in

1 reference

16 August 2017

volume

8

1 reference

16 August 2017

issue

1

1 reference

16 August 2017

page(s)

13-22

1 reference

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2007.002

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2007.002

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2007.002

Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2007.002

Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2007.002

The QUinapril Ischemic Event Trial (QUIET): evaluation of chronic ACE inhibitor therapy in patients with ischemic heart disease and preserved left ventricular function

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2007.002

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2007.002

Angiotensin-converting-enzyme inhibition in stable coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2007.002

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2007.002

A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2007.002

Angiotensin-Converting Enzyme Inhibitors and Calcium Channel Blockers for Coronary Heart Disease and Stroke Prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2007.002

Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2007.002

Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2007.002

Angiotensin-converting enzyme inhibition as antiatherosclerotic therapy: no answer yet. QUIET Investigators. QUinapril Ischemic Event Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2007.002

Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2007.002

Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA).

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2007.002

The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2007.002

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2007.002

The effect of perindopril on cardiovascular morbidity and mortality in patients with diabetes in the EUROPA study: results from the PERSUADE substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2007.002

Blood-pressure reduction and cardiovascular risk in HOPE study

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2007.002

Comparative effects of ramipril on ambulatory and office blood pressures: a HOPE Substudy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2007.002

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2007.002

Predictive value of clinic and ambulatory heart rate for mortality in elderly subjects with systolic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2007.002

Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with symptomatic stable angina and hypertension: the ACTION trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2007.002

Benefits and safety of long-acting calcium antagonists in coronary artery disease: the Action Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2007.002

The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2007.002

Renin-angiotensin system and atherothrombotic disease: from genes to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2007.002

Class effect of angiotensin-converting enzyme inhibitors on prevention of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2007.002

Mortality rates in elderly patients who take different angiotensin-converting enzyme inhibitors after acute myocardial infarction: a class effect?

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2007.002

Different effect of antihypertensive drugs on conduit artery endothelial function

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2007.002

Perindopril alters vascular angiotensin-converting enzyme, AT(1) receptor, and nitric oxide synthase expression in patients with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2007.002

Losartan and perindopril effects on plasma plasminogen activator inhibitor-1 and fibrinogen in hypertensive type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2007.002

21 January 2018

Identifiers

DOI

10.3317/JRAAS.2007.002

1 reference

16 August 2017

1 reference